Skip to main content
Clinical Trials/DRKS00020222
DRKS00020222
Recruiting
Phase 4

Guided bone regeneration of peri-implant defects with particulate versus soft-type block bone substitutes. A randomized controlled, single blinded clinical trial - L-Shape

Clinic of Reconstructive DentistryCenter of Dental MedicineUniversity of Zürich0 sites64 target enrollmentJune 15, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
K00-K14
Sponsor
Clinic of Reconstructive DentistryCenter of Dental MedicineUniversity of Zürich
Enrollment
64
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 15, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Clinic of Reconstructive DentistryCenter of Dental MedicineUniversity of Zürich

Eligibility Criteria

Inclusion Criteria

  • Patients, in need of at least one implant with an expected peri\-implant bone dehiscence \= 2 mm of apico\-coronal dimension in the maxilla or mandible (excl. molars)
  • \-primary implant stability assessed at implant placement
  • \-no need of soft tissue grafting after implant placement
  • \-tooth extraction performed \= 4 months in advance
  • \-possibly performed soft tissue grafting \= 2 months in advance
  • \-Presence of one adjacent tooth at the implant site;
  • \-Presence of antagonist;
  • \-Adequate oral hygiene (Bleeding on probing \<20%; Plaque index \<20%);
  • \-Capability to comply with the study procedures
  • \-Signed Informed Consent Form

Exclusion Criteria

  • \-Ridge preservation procedure after tooth extraction performed
  • \-Pregnant or lactating women;
  • \-Known or suspected non\-compliance, drug or alcohol abuse
  • \-Smokers (\>10 cigarettes/day including e\-cigarettes)
  • \-Currently taking drugs that influence bone metabolism
  • \-Use of bisphosphonates in the last 4 years
  • \-Systemic or local conditions presenting a contraindication to implant treatment
  • \-History of malignancy, radiotherapy or chemotherapy for malignancy in the past 5 years

Outcomes

Primary Outcomes

Not specified

Similar Trials